| Literature DB >> 32030366 |
Kentaro Miura1, Nobutaka Kobayashi1, Ichiro Ito2, Nozomu Uematsu3, Toshimitsu Ueki3, Yuta Nakano4, Hikaru Kobayashi3.
Abstract
Pulmonary mucormycosis is relatively rare and occurs in immunosuppressed patients, for example, individuals with hematologic malignancies such as leukemia. As pulmonary mucormycosis increases rapidly and is often fatal, appropriate treatment including surgical resection is necessary. We report a patient with pulmonary mucormycosis and acute myelogenous leukemia for which antifungal drugs were invalid. After rapid surgical resection, the patient was administered a peripheral blood stem cell transplantation. In conclusion, we emphasize that patients with pulmonary mucormycosis undergoing leukemia treatment should be considered for rapid surgical treatment if the infected lesion is limited, as overcoming this acute infection increases their chance to undergo hematopoietic stem cell transplantation and potential for long-term survival. 2019 AME Case Reports. All rights reserved.Entities:
Keywords: Pulmonary mucormycosis; leukemia; peripheral blood stem cell transplantation; surgical resection
Year: 2019 PMID: 32030366 PMCID: PMC6987314 DOI: 10.21037/acr.2019.11.02
Source DB: PubMed Journal: AME Case Rep ISSN: 2523-1995